2 completed, 2 recruiting. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow Breastfeeding: new trials by email Literature Review of Breastfeeding trials Research Report on Breastfeeding
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women Standard dose rifampicin, High dose rifampicin, Standard dose isoniazid - Tuberculosis Infection, Healthy Volunteer | Phase 1 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 60 | 2026-06-01 | 2026-11-02 |
| Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation 5-MTHF Supplementation, Placebo - Breastfeeding | Phase 1 / Phase 2 | Recruiting | Fundació Sant Joan de Déu | 36 | 2026-04-15 | 2026-11-12 |
| Excretion of Rivaroxaban in Human Breast Milk Rivaroxaban 10 MG Oral Tablet, Rivaroxaban 20 MG Oral Tablet - Postpartum, VTE Prophylaxis | Phase 1 | Recruiting | Thomas Jefferson University | 10 | 2025-07-01 | 2025-07-17 |
| Early Breastfeeding Cessation - is It Possible to Prevent? community based trial - Breastfeeding, Practice | Phase 1 | Completed | University of Aarhus | 1456 | 2004-02-01 | 2005-09-05 |
Breast Feeding (4) · Breast Milk Expression (1) · Latent Tuberculosis (1) · Venous Thromboembolism (1)
Behavior (4) · Feeding Behavior (4) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Latent Infection (1) · Mycobacterium Infections (1) · Thromboembolism (1) · Tuberculosis (1) · Vascular Diseases (1)
Isoniazid (1) · Levofloxacin (1) · Rifampin (1) · Rivaroxaban (1) · Tablets (1) · bedaquiline (1) · rifapentine (1)
Fundació Sant Joan de Déu (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Thomas Jefferson University (1) · University of Aarhus (1)
Denmark (1) · Indonesia (1) · Spain (1) · United States (1)
Carles Lerin, PhD (1) · Dick Menzies, MD (1) · Ingegerd Harder, Ph.D. (1)